Literature DB >> 20820100

Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides.

Andreas Cederlund1, Birgitta Agerberth, Peter Bergman.   

Abstract

Neutrophil-derived antimicrobial peptides and proteins (AMPs) play an important role in the defense against microbes. Absence of defense is illustrated by neutropenic patients with frequent bacterial and fungal infections. However, the specificity of the antimicrobial effects has not been adequately described. We set out to determine the specific antimicrobial pattern of polypeptides in neutrophils (polymorphonuclear leukocytes, PMNs) against 4 potential human pathogens: Moraxella catarrhalis, Staphylococcus aureus, Haemophilus influenzae and Candida albicans. Protein extracts of human PMNs were separated using high-performance liquid chromatography and fractions were assayed for antimicrobial activity. Fractions displaying antimicrobial activity were separated on SDS-PAGE and characterized using MALDI-MS. Depletion experiments were utilized to determine the contribution of each AMP to the antimicrobial effect. Among the identified AMPs, α-defensins 1-3, azurocidin, LL-37, lysozyme, calprotectin and lactotransferrin were studied in detail. We found a divergent pattern of killing, that is, certain peptides and proteins exhibited selective activity against specific pathogens, while others displayed a broader antimicrobial activity. α-Defensins, LL-37 and calprotectin were active against all species, while lactotransferrin exclusively inhibited growth of S. aureus. Conversely, azurocidin was active against all species except S. aureus. Our observations may shed light on bacterial resistance to AMPs and on the elimination of specific bacterial communities on mucosal surfaces.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20820100     DOI: 10.1159/000317665

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  12 in total

Review 1.  Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections.

Authors:  Charles R Wira; Mickey V Patel; Mimi Ghosh; Lucy Mukura; John V Fahey
Journal:  Am J Reprod Immunol       Date:  2011-03       Impact factor: 3.886

2.  Interleukin 13 exposure enhances vitamin D-mediated expression of the human cathelicidin antimicrobial peptide 18/LL-37 in bronchial epithelial cells.

Authors:  J A Schrumpf; M A J A van Sterkenburg; R M Verhoosel; S Zuyderduyn; P S Hiemstra
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

3.  Label-free quantitative mass spectrometry reveals novel pathways involved in LL-37 expression.

Authors:  Andreas Cederlund; Frank Nylén; Erica Miraglia; Peter Bergman; Gudmundur H Gudmundsson; Birgitta Agerberth
Journal:  J Innate Immun       Date:  2013-11-16       Impact factor: 7.349

4.  Studies on the antibacterial effects of statins--in vitro and in vivo.

Authors:  Peter Bergman; Charlotte Linde; Katrin Pütsep; Anton Pohanka; Staffan Normark; Birgitta Henriques-Normark; Jan Andersson; Linda Björkhem-Bergman
Journal:  PLoS One       Date:  2011-08-30       Impact factor: 3.240

5.  Impaired release of antimicrobial peptides into nasal fluid of hyper-IgE and CVID patients.

Authors:  Andreas Cederlund; Marie Olliver; Rokeya Sultana Rekha; Monica Lindh; Lennart Lindbom; Staffan Normark; Birgitta Henriques-Normark; Jan Andersson; Birgitta Agerberth; Peter Bergman
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

6.  Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children.

Authors:  Anna Rautanen; Matti Pirinen; Tara C Mills; Kirk A Rockett; Amy Strange; Anne W Ndungu; Vivek Naranbhai; James J Gilchrist; Céline Bellenguez; Colin Freeman; Gavin Band; Suzannah J Bumpstead; Sarah Edkins; Eleni Giannoulatou; Emma Gray; Serge Dronov; Sarah E Hunt; Cordelia Langford; Richard D Pearson; Zhan Su; Damjan Vukcevic; Alex W Macharia; Sophie Uyoga; Carolyne Ndila; Neema Mturi; Patricia Njuguna; Shebe Mohammed; James A Berkley; Isaiah Mwangi; Salim Mwarumba; Barnes S Kitsao; Brett S Lowe; Susan C Morpeth; Iqbal Khandwalla; Jenefer M Blackwell; Elvira Bramon; Matthew A Brown; Juan P Casas; Aiden Corvin; Audrey Duncanson; Janusz Jankowski; Hugh S Markus; Christopher G Mathew; Colin N A Palmer; Robert Plomin; Stephen J Sawcer; Richard C Trembath; Ananth C Viswanathan; Nicholas W Wood; Panos Deloukas; Leena Peltonen; Thomas N Williams; J Anthony G Scott; Stephen J Chapman; Peter Donnelly; Adrian V S Hill; Chris C A Spencer
Journal:  Am J Hum Genet       Date:  2016-05-26       Impact factor: 11.025

Review 7.  Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens.

Authors:  Soledad R Ordonez; Edwin J A Veldhuizen; Martin van Eijk; Henk P Haagsman
Journal:  Front Microbiol       Date:  2017-10-31       Impact factor: 5.640

8.  Cellular responses of Candida albicans to phagocytosis and the extracellular activities of neutrophils are critical to counteract carbohydrate starvation, oxidative and nitrosative stress.

Authors:  Pedro Miramón; Christine Dunker; Hanna Windecker; Iryna M Bohovych; Alistair J P Brown; Oliver Kurzai; Bernhard Hube
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

9.  Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasis.

Authors:  Andreas Cederlund; Ylva Kai-Larsen; Gordana Printz; Hiroyuki Yoshio; Gunvor Alvelius; Hugo Lagercrantz; Roger Strömberg; Hans Jörnvall; Gudmundur H Gudmundsson; Birgitta Agerberth
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

10.  Vitamin D3 Supplementation and Antibiotic Consumption - Results from a Prospective, Observational Study at an Immune-Deficiency Unit in Sweden.

Authors:  Anna-Carin Norlin; Susanne Hansen; Emilie Wahren-Borgström; Carl Granert; Linda Björkhem-Bergman; Peter Bergman
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.